Avandaryl combines Avandia and Amaryl, two other diabetes drugs for the control of blood sugar levels. As an adjunct to diet and exercise, Avandaryl is indicated to improve blood sugar control in patients with type 2 diabetes who are not being sufficiently.
Type 2 diabetes is characterized by high blood sugar levels that occur when the body does not produce enough insulin or does not respond properly to its own natural insulin, a condition called insulin resistance.
“Avandaryl, a combination of rosiglitazone and a sulfonylurea, provides two different, yet complementary, mechanisms of action to treat diabetes by improving blood sugar control in patients with type 2 diabetes. The patient’s treatment regimen combines these two medicines into one convenient tablet,” said Dr Barry Goldstein, director, division of endocrinology, diabetes and metabolic diseases, Jefferson Medical College, Philadelphia.